These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151 [TBL] [Abstract][Full Text] [Related]
3. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E). Karreth FA; DeNicola GM; Winter SP; Tuveson DA Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255 [TBL] [Abstract][Full Text] [Related]
4. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789 [TBL] [Abstract][Full Text] [Related]
5. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells]. Wang X; Lu R; Fang JY Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425 [TBL] [Abstract][Full Text] [Related]
6. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. de Keizer PL; Packer LM; Szypowska AA; Riedl-Polderman PE; van den Broek NJ; de Bruin A; Dansen TB; Marais R; Brenkman AB; Burgering BM Cancer Res; 2010 Nov; 70(21):8526-36. PubMed ID: 20959475 [TBL] [Abstract][Full Text] [Related]
7. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
8. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615 [TBL] [Abstract][Full Text] [Related]
9. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway. Cozzi SJ; Parsons PG; Ogbourne SM; Pedley J; Boyle GM Cancer Res; 2006 Oct; 66(20):10083-91. PubMed ID: 17047072 [TBL] [Abstract][Full Text] [Related]
10. B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells. Cui Y; Guadagno TM Oncogene; 2008 May; 27(22):3122-33. PubMed ID: 18071315 [TBL] [Abstract][Full Text] [Related]
11. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. Sharma A; Tran MA; Liang S; Sharma AK; Amin S; Smith CD; Dong C; Robertson GP Cancer Res; 2006 Aug; 66(16):8200-9. PubMed ID: 16912199 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. Gysin S; Lee SH; Dean NM; McMahon M Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308 [TBL] [Abstract][Full Text] [Related]
13. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. Houben R; Vetter-Kauczok CS; Ortmann S; Rapp UR; Broecker EB; Becker JC J Invest Dermatol; 2008 Aug; 128(8):2003-12. PubMed ID: 18323787 [TBL] [Abstract][Full Text] [Related]
14. FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells. Abel EV; Aplin AE Cancer Res; 2010 Apr; 70(7):2891-900. PubMed ID: 20332228 [TBL] [Abstract][Full Text] [Related]
15. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence. Shin J; Yang J; Lee JC; Baek KH Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963 [TBL] [Abstract][Full Text] [Related]
16. Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth. Hao H; Muniz-Medina VM; Mehta H; Thomas NE; Khazak V; Der CJ; Shields JM Mol Cancer Ther; 2007 Aug; 6(8):2220-9. PubMed ID: 17699719 [TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152. Kim YK; Ahn SK; Lee M Cancer Lett; 2012 Jul; 320(2):215-24. PubMed ID: 22425959 [TBL] [Abstract][Full Text] [Related]
18. Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma. Leung GP; Feng T; Sigoillot FD; Geyer FC; Shirley MD; Ruddy DA; Rakiec DP; Freeman AK; Engelman JA; Jaskelioff M; Stuart DD Mol Cancer Res; 2019 Jan; 17(1):199-211. PubMed ID: 30201825 [TBL] [Abstract][Full Text] [Related]
19. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281 [TBL] [Abstract][Full Text] [Related]